Access Statistics for Odd Rune Straume

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A dynamic model of quality competition with endogenous prices 0 0 0 12 1 3 5 79
Access regulation and cross-border mergers: Is international coordination beneficial? 0 0 0 7 0 0 0 46
Access regulation and cross-border mergers: Is international coordination beneficial? 0 0 0 61 2 3 3 221
Are cooperatives more productive than investor-owned firms? Cross-industry evidence from Portugal 0 0 0 68 2 3 3 101
Bilateral monopolies and location choice 0 0 0 19 0 4 5 78
Can Competition Reduce Quality? 0 0 1 48 0 0 1 292
Can Deunionization Lead to International Outsourcing? 0 0 0 16 0 0 1 113
Can Deunionization Lead to International Outsourcing? 0 0 0 133 0 1 2 516
Can competition reduce quality? 0 0 0 123 1 1 3 193
Can competition reduce quality? 0 0 0 38 1 1 1 81
Can competition reduce quality? 0 0 1 109 2 2 3 306
Can deunionization lead to international outsourcing? 0 0 0 4 0 0 0 83
Can deunionization lead to international outsourcing? 0 0 0 5 0 1 1 87
Competing with precision: incentives for developing predictive biomarker tests 0 0 0 14 1 1 1 15
Competing with precision: incentives for developing predictive biomarker tests 0 0 0 27 0 0 0 10
Competition and Equity in Health Care Markets 0 0 1 58 0 1 6 155
Competition and Physician Behaviour: Does the Competitive Environment Affect the Propensity to Issue Sickness Certificates? 0 0 0 11 0 0 1 42
Competition and Quality in Regulated Markets with Sluggish Demand 0 0 0 45 0 0 1 206
Competition and Quality in Regulated Markets: a Differential-Game Approach 0 0 0 82 0 1 2 384
Competition and Waiting Times in Hospital Markets 0 0 0 108 2 3 4 412
Competition and Waiting Times in Hospital Markets 0 0 0 143 0 3 4 579
Competition and Waiting Times in Hospital Markets 0 0 0 84 0 2 4 422
Competition and physician behaviour: Does the competitive environment the propensity to issue sickness certificates? 0 0 0 70 0 0 0 77
Competition and quality in regulated markets with sluggish demand 0 0 0 44 1 1 2 181
Competition and quality in regulated markets: a differential-game approach 0 1 1 150 0 4 5 491
Competition and quality in regulated markets: a differential-game approach 0 0 0 88 0 1 1 244
Competition matters: uniform vs. indication-based pricing of pharmaceuticals 0 0 2 2 0 3 9 9
Competition matters: uniform vs. indication-based pricing of pharmaceuticals 0 0 15 15 1 6 28 28
Competition, quality and integrated health care 0 0 2 67 0 0 3 76
Cross border mergers and strategic trade policy with two-part taxation: is international policy coordination beneficial? 0 0 0 23 0 0 2 141
Do Hospital Mergers Reduce Waiting Times? Theory and Evidence from the English NHS 0 0 0 23 1 1 2 19
Do Hospital Mergers Reduce Waiting Times? Theory and Evidence from the English NHS 0 0 0 0 0 0 2 9
Do Hospital Mergers Reduce Waiting Times? Theory and Evidence from the English NHS 0 0 0 12 0 1 4 25
Do Treatment Decisions Depend on Physicians` Financial Incentives? 0 0 0 36 0 0 0 50
Do Treatment Decisions Depend on Physicians’ Financial Incentives? 0 0 0 10 0 1 3 67
Do hospital mergers reduce waiting times? Theory and evidence from the english NHS 0 1 1 31 0 5 11 29
Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform 0 0 0 22 0 0 2 14
Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform 0 0 0 18 0 1 1 86
Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform 0 0 0 72 0 0 2 152
Does Remote Work Improve or Impair Firm Labour Productivity? Longitudinal Evidence from Portugal 1 1 4 153 1 5 16 388
Does monetary punishment crowd out pro-social motivation? The case of hospital bed-blocking 0 0 0 79 0 2 6 444
Does remote work improve or impair firm labour productivity? Longitudinal evidence from 0 0 7 397 2 3 32 1,329
Downstream Merger with Oligopolistic Input Suppliers 0 0 0 94 1 1 1 543
Downstream merger with oligopolistic input suppliers 0 0 0 7 0 0 0 89
Dynamic Hospital Competition Under Rationing by Waiting Times 0 0 0 29 0 0 1 66
Dynamic hospital competition under rationing by waiting times 0 0 0 48 0 0 1 84
Economic integration and environmental policy coordination 0 0 0 9 0 1 3 51
Employment Protection versus Flexicurity: On Technology Adoption in Unionised Firms 0 0 0 81 1 1 1 259
Employment protection and unemployment benefits: On technology adoption and job creation in a matching model 0 0 0 94 1 1 4 67
Employment protection and unemployment benefits: On technology adoption and job creation in a matching model 0 0 0 66 2 2 3 189
Employment protection and unemployment benefits: on technology adoption and job creation in a matching model 0 0 0 22 1 1 3 96
Employment protection versus flexicurity: on technology adoption in unionised firms 0 0 0 32 0 2 4 132
Firm Heterogeneity and Wages in Unionised Labour Markets: Theory and Evidence 0 0 0 30 0 0 2 113
Firm Ownership and Rent Sharing 0 1 1 20 0 2 2 96
Firm heterogeneity and wages in unionised labour markets: Theory and evidence 0 0 0 69 0 0 1 198
Firm ownership and rent sharing 0 0 0 16 0 0 0 97
Foreign acquisition and internal organization 0 0 0 29 0 0 0 103
Foreign acquisition and internal organization 0 0 0 67 0 0 2 144
Gatekeeping In Health Care 0 0 0 148 0 0 2 605
Gatekeeping in Health Care 0 0 0 252 0 0 2 1,811
Globalisation And Union Opposition To Technological Change 0 0 0 80 0 0 9 249
Globalisation and union opposition to technological change 0 0 0 7 0 2 6 92
Globalisation and union opposition to technological change 0 0 0 5 0 0 0 95
Globalization and Union Opposition to Technological Change 0 0 0 143 0 0 0 976
Globalization, Product Differentiation and Wage Inequality 0 0 0 70 0 0 1 187
Globalization, Product Differentiation and Wage Inequality 0 0 0 1 0 0 0 30
Globalization, product differentiation and wage inequality 0 0 0 60 1 2 2 209
Globalization, product differentiation and wage inequality 0 0 0 74 1 1 3 357
Good Jobs, Bad Jobs and Redistribution 0 0 0 0 0 0 0 644
Good Jobs, Bad Jobs and Redistribution 0 0 0 39 1 1 1 272
Good jobs, bad jobs and redistribution 0 0 0 44 0 0 1 317
Good jobs, bad jobs and redistribution 0 0 0 2 0 0 0 76
Horizontal Mergers and Product Quality 0 0 0 33 0 0 2 130
Horizontal Mergers and Product Quality 0 0 0 28 0 0 0 61
Horizontal Mergers and Product Quality 0 0 0 35 0 0 0 109
Horizontal Mergers and Product Quality- 0 0 0 60 0 0 0 141
Hospital Competition and Quality with Regulated Prices 0 0 0 306 0 1 2 1,109
Hospital Competition in the National Health Service: Evidence from a Patient Choice Reform 0 0 0 70 0 1 2 141
Hospital Competition in the National Health Service: Evidence from a Patient Choice Reform 0 0 1 32 1 1 3 63
Hospital Competition under Pay-for-Performance: Quality, Mortality and Readmissions 0 0 2 35 2 2 7 194
Hospital Competition under Pay-for-Performance: Quality, Mortality and Readmissions 0 0 2 101 0 1 5 133
Hospital Competition with Soft Budgets 0 0 0 48 0 1 1 193
Hospital Mergers with Regulated Prices 0 0 0 90 1 1 3 141
Hospital Mergers: A Spatial Competition Approach 0 0 0 37 0 0 2 127
Hospital Mergers: A Spatial Competition Approach 0 0 0 121 1 1 1 116
Hospital competition and quality with regulated prices 0 0 0 149 0 2 3 387
Hospital competition when patients learn through experience 0 0 0 27 0 0 2 9
Hospital competition with soft budgets 0 0 0 74 0 0 0 150
Hospital competition with soft budgets 0 0 0 31 0 0 1 62
Hospital competition with soft budgets 0 0 0 46 0 0 0 123
How does the type of remuneration affect physician behaviour? Fixed salary versus fee-for-service 0 0 2 72 0 1 3 143
Industry Concentration and Strategic Trade Policy in Successive Oligopoly 0 0 0 161 1 2 3 632
Industry concentration and strategic trade policy in successive oligopoly 0 0 0 13 0 0 0 68
International mergers and trade liberalisation: Implications for unionised 0 0 0 1 0 0 0 349
International outsourcing and trade union (de-)centralisation 0 0 1 18 0 0 2 50
Investment and Quality Competition in Healthcare Markets 0 0 0 30 0 1 3 68
Management, Performance And Pay 0 0 1 22 2 2 3 23
Managerial delegation and merger incentives 0 0 0 7 0 0 0 31
Margins and Market Shares: Pharmacy Incentives for Generic Substitution 0 0 2 36 0 2 6 207
Margins and Market Shares: Pharmacy Incentives for Generic Substitution 0 0 0 114 0 0 1 122
Margins and Market Shares:Pharmacy Incentives for Generic Substitution 0 0 0 91 0 0 0 224
Merger Profitability in Unionized Oligopoly 0 0 0 0 0 0 1 341
Merger Profitability in Unionized Oligopoly 0 0 0 0 0 0 1 508
Merger Profitability in Unionized Oligopoly 0 0 0 95 0 0 2 408
Merger Profitability in Unionized Oligopoly 0 0 0 7 0 0 0 33
Merger control in retail markets with national pricing 0 0 0 27 0 0 0 12
Merger, partial collusion and relocation 0 0 0 162 0 0 0 492
Merger, partial collusion and relocation 0 0 1 3 0 0 6 52
Mergers and capital flight in unionised oligopolies: Is there scope for a 'national champion' policy? 0 0 0 50 2 3 3 163
Mergers and capital flight in unionised oligopolies: Is there scope for a 'national champion' policy? 0 0 0 7 0 0 1 94
Mommy tracks and public policy: On self-fulfilling prophecies and gender gaps in promotion 0 0 1 36 0 0 4 161
National pricing with local quality competition 0 0 0 9 0 1 5 24
National pricing with local quality competition 0 0 0 24 0 1 1 61
National versus International Mergers in Unionised Oligopoly 0 0 0 132 2 2 2 509
National versus international mergers in unionised oligopoly 0 0 0 27 0 0 0 94
North-South Technology Transfer in Unionised Multinationals 0 0 0 17 0 0 1 122
North-South technology transfer in unionised multinationals 0 0 0 39 1 1 1 122
North-South technology transfer in unionised multinationals 0 0 0 16 0 0 0 156
North-South technology transfer in unionised multinationals 0 0 0 14 0 0 0 77
Optimal dynamic volume-based price regulation 0 0 0 45 0 0 0 68
Outsourcing in Contests 0 0 0 90 1 1 1 326
Outsourcing in Contests 0 1 1 17 0 1 1 78
Patents: Incentives for R&D or Marketing? 0 0 0 9 0 0 2 51
Patient Mobility, Health Care Quality and Welfare 0 0 1 51 0 0 3 152
Patient Mobility, Health Care Quality and Welfare 0 1 1 54 0 1 2 121
Patient Mobility, Health Care Quality and Welfare 0 0 0 45 1 2 3 165
Patient Mobility, Health Care Quality and Welfare 0 0 0 42 0 1 2 122
Patient mobility and health care quality when regions and patients differ in income 0 1 1 14 0 1 2 67
Pharmaceutical Patents: Incentives for R&D or Marketing? 0 0 0 275 0 0 3 1,091
Preschool Education in Brazil: Does Public Supply Crowd Out Private Enrollment? 0 0 0 2 0 0 0 15
Preschool Education in Brazil: Does Public Supply Crowd Out Private Enrollment? 0 0 0 47 0 0 0 73
Preschool education in Brazil: does public supply crowd out private enrollment ? 0 0 0 21 0 0 1 49
Preschool education in Brazil:Does public supply crowd out private enrollment? 0 0 0 176 1 1 6 106
Price Regulation and Parallel Imports of Pharmaceuticals 0 0 0 95 2 2 3 146
Price Regulation and Parallel Imports of Pharmaceuticals 0 0 0 13 2 3 5 119
Price Regulation and Parallel Imports of Pharmaceuticals 0 0 0 100 0 0 0 118
Price and quality in spatial competition 0 0 0 162 0 2 6 254
Price and quality in spatial competition 0 0 0 94 0 0 0 225
Privatization and corporate restructuring 0 0 0 35 0 0 3 145
Public coverage of dental care: universal or targeted? 0 0 0 0 2 3 6 6
Public coverage of dental care: universal or targeted? 1 1 8 8 1 5 9 9
Quality and location choices under price regulation 0 0 0 25 0 1 2 107
Quality and location choices under price regulation 0 0 0 21 0 1 2 109
Quality competition with motivated providers and sluggish demand 0 0 0 8 1 1 8 143
Quality competition with motivated providers and sluggish demand 0 0 0 59 0 1 2 126
Quality competition with profit constraints: Do non-profit firms provide higher quality than for-profit firms? 0 0 0 44 0 1 1 146
Quality competition with profit constraints: Do non-profit firms provide higher quality than for-profit firms? 0 0 1 84 2 3 4 121
Quality competition with profit constraints: Do non-profit firms provide higher quality than for-profit firms? 0 0 0 108 0 0 0 202
Quality discrimination in healthcare markets 0 0 1 23 1 1 2 14
Quality provision in hospital markets with demand inertia:The role of patient expectations 0 0 1 25 0 0 5 59
Rain, agriculture, and tariffs 0 0 0 30 1 1 1 69
Rain, food and tariffs 0 0 0 19 0 1 1 86
Reference Pricing of Pharmaceuticals 0 0 0 269 0 0 1 931
Reference Pricing of Pharmaceuticals 0 0 0 20 0 0 0 121
Reference Pricing, Competition, and Pharmaceutical Expenditures: Theory and Evidence from a Natural Experiment 0 0 8 111 1 1 13 398
Reference pricing with endogenous generic entry 0 0 0 16 0 0 1 76
Reference pricing with endogenous generic entry 0 0 0 52 0 0 0 90
Regulation, generic competition and pharmaceutical prices: Theory and evidence from a natural experiment 0 0 2 149 0 2 5 490
Rent-Seeking in a Unionised Monopoly 0 0 0 1 0 1 1 322
Restructuring in privatised firms: a Statis approach 0 0 1 20 0 1 3 119
Restructuring in privatised firms:a Statis approach 0 0 1 5 0 0 1 125
Socioeconomic Status and PhysiciansíTreatment Decisions 0 0 0 19 1 1 1 59
Socioeconomic Status and Physicians’ Treatment Decisions 0 0 0 10 1 1 2 71
Taking the competitor´s pill: when combination therapies enter pharmaceutical markets 0 0 0 0 0 0 0 4
Taking the competitor’s pill: when combination therapies enter pharmaceutical markets 0 0 0 12 2 2 4 25
Technology resistance and globalisation with trade unions: the choice between employment protection and flexicurity 0 0 0 16 0 2 4 164
Technology resistance and globalisation with trade unions: the choice between employment protection and flexicurity 0 0 0 122 0 0 1 485
The Division of Revenues from Unexpected Demand Shocks 0 0 2 2 0 0 6 6
The Division of Unexpected Revenue Shocks 0 0 0 22 0 0 0 37
The effect of private versus public ownership on labour earnings 0 0 0 27 1 1 2 110
The price of cost-effectiveness thresholds 0 1 2 27 0 1 3 16
The price of cost-effectiveness thresholds 0 0 0 24 0 1 4 15
Trade, renewable energy, and market power in power markets 0 0 0 15 3 3 5 37
Union Collusion and Intra-Industry Trade 0 0 0 0 0 0 0 675
Total Working Papers 2 9 80 9,498 64 159 463 34,326
2 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A dynamic model of quality competition with endogenous prices 0 0 2 27 1 1 5 112
ARE COOPERATIVES MORE PRODUCTIVE THAN INVESTOR-OWNED FIRMS? CROSS-INDUSTRY EVIDENCE FROM PORTUGAL 0 0 0 26 3 5 10 198
Bilateral monopolies and location choice 0 0 0 47 0 0 1 176
Can Competition Reduce Quality? 0 0 1 34 0 1 4 177
Can deunionization lead to international outsourcing? 0 0 0 74 0 1 1 293
Company Taxation and Merger Incentives in International Oligopoly: on International Policy Coordination with Strategic Trade 0 0 0 17 0 0 0 98
Competing with precision: incentives for developing predictive biomarker tests 0 0 0 0 0 0 2 3
Competition and equity in health care markets 0 0 1 22 0 2 4 91
Competition and physician behaviour: Does the competitive environment affect the propensity to issue sickness certificates? 0 0 1 3 0 2 4 27
Competition and quality in health care markets: A differential-game approach 0 0 0 48 1 3 10 240
Competition and waiting times in hospital markets 0 0 1 133 1 3 4 506
Competition in Regulated Markets with Sluggish Beliefs about Quality 0 0 0 18 0 0 2 78
Competition policy for health care provision in Norway 0 0 0 5 0 0 0 36
Competition, quality and integrated health care 0 0 1 4 0 1 7 13
Do treatment decisions depend on physicians' financial incentives? 0 1 7 43 1 6 21 165
Does monetary punishment crowd out pro-social motivation? A natural experiment on hospital length of stay 0 0 2 56 0 1 3 187
Downstream merger with upstream market power 0 0 0 114 1 1 2 522
Dynamic hospital competition under rationing by waiting times 0 0 0 8 0 2 4 34
Editorial note 0 0 0 8 0 0 0 41
Employment Protection Versus Flexicurity: On Technology Adoption in Unionised Firms 0 0 0 20 0 0 1 89
Employment Protection and Unemployment Benefits: On Technology Adoption and Job Creation in a Matching Model 0 0 0 9 0 1 2 67
Firm Ownership and Rent Sharing 0 0 0 9 1 1 2 77
Firm heterogeneity and wages in unionised labour markets: Theory and evidence 0 0 1 38 1 3 5 150
Foreign acquisition and internal organization 0 0 3 29 0 0 4 136
Gatekeeping in health care 0 0 0 170 0 0 3 738
Globalisation and union opposition to technological change 0 0 0 94 0 0 0 372
Globalization, product differentiation, and wage inequality 0 0 0 3 0 1 3 25
Globalization, product differentiation, and wage inequality 0 0 0 35 0 0 0 185
Good Jobs, Bad Jobs and Redistribution* 0 0 0 44 0 0 1 289
Horizontal mergers and product quality 0 0 0 8 0 1 3 56
Horizontal mergers and product quality 0 0 0 2 0 0 1 32
Hospital Competition and Quality with Regulated Prices 0 0 0 58 1 1 7 197
Hospital Competition with Soft Budgets 0 0 0 9 0 1 3 64
Hospital Mergers with Regulated Prices 0 0 0 5 0 1 1 58
Hospital competition in a national health service: Evidence from a patient choice reform 0 0 1 6 0 2 10 32
Hospital competition under pay‐for‐performance: Quality, mortality, and readmissions 0 0 2 9 0 2 10 66
Hospital competition when patients learn through experience 0 0 0 0 0 0 8 8
How Does The Type of Remuneration Affect Physician Behavior? 0 0 2 30 2 4 13 90
Industry Concentration and Strategic Trade Policy in Successive Oligopoly 0 0 0 31 1 1 2 130
International mergers and trade liberalisation: implications for unionised labour 0 0 0 41 0 0 1 195
International outsourcing and trade union (de-)centralisation 0 0 0 2 0 1 2 11
Investment and quality competition in healthcare markets 0 0 1 4 0 3 5 22
Management Practices, Pay, and Pay Inequality 0 0 1 2 0 2 8 9
Managerial Delegation and Merger Incentives with Asymmetric Costs 0 0 0 79 0 1 1 263
Margins and market shares: Pharmacy incentives for generic substitution 0 0 0 55 1 3 10 326
Merger Control in Retail Markets with National Pricing 0 0 0 0 3 3 4 4
Merger, Partial Collusion and Relocation 0 0 0 6 0 1 2 59
Mergers and capital flight in unionised oligopolies: Is there scope for a "national champion" policy? 0 0 0 19 1 2 4 92
Mommy tracks and public policy: On self-fulfilling prophecies and gender gaps in hiring and promotion 1 2 6 59 1 2 12 185
National pricing with local quality competition 0 0 0 2 1 2 7 12
National versus international mergers in unionized oligopoly 0 0 1 18 1 1 4 79
North–South technology transfer in unionised multinationals 0 0 0 25 0 1 3 154
Optimal dynamic volume-based price regulation 0 0 1 5 0 4 6 28
Optimal funding coverage in a mixed oligopoly with quality competition and price regulation 0 0 1 9 0 0 4 19
Outsourcing in contests 0 0 1 46 0 0 2 232
Patient mobility and health care quality when regions and patients differ in income 0 0 0 17 1 2 2 77
Patient mobility, health care quality and welfare 0 0 1 22 0 2 4 101
Paying for pharmaceuticals: uniform pricing versus two-part tariffs 0 0 0 3 0 1 2 20
Pharmaceutical Patents: Incentives for Research and Development or Marketing? 0 0 0 0 2 3 3 5
Preschool Education in Brazil: Does Public Supply Crowd Out Private Enrollment? 0 0 1 10 0 1 4 86
Price and quality in spatial competition 0 0 0 57 0 2 7 246
Price regulation and parallel imports of pharmaceuticals 0 0 1 24 0 0 6 113
Product Market Integration and Environmental Policy Coordination in An International Duopoly 0 0 0 47 0 0 0 172
Quality and Location Choices under Price Regulation 0 0 2 170 0 0 5 497
Quality competition with motivated providers and sluggish demand 0 0 0 12 0 0 1 127
Quality competition with profit constraints 0 0 1 33 1 3 11 167
Quality discrimination in healthcare markets 0 0 0 0 0 0 1 1
Quality provision in hospital markets with demand inertia: The role of patient expectations 0 0 1 4 0 0 2 10
Rain, agriculture, and tariffs 0 0 0 39 0 2 6 167
Reference pricing of pharmaceuticals 0 0 1 97 0 0 1 257
Reference pricing with endogenous generic entry 0 0 0 12 0 2 3 59
Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment 1 1 1 74 1 1 4 251
Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment 0 0 0 75 1 2 4 338
Rent-seeking in a unionised monopoly 0 0 0 29 1 1 1 189
Restructuring in privatised firms: A Statis approach 0 0 1 15 1 2 4 77
Socio‐economic status and physicians' treatment decisions 0 1 1 7 0 1 2 33
Taking the competitor’s pill: When combination therapies enter pharmaceutical markets 0 0 0 0 0 0 0 0
The effect of private versus public ownership on labour earnings 0 0 0 4 1 1 1 50
The impact of private vs. public ownership on the level and structure of employment 0 0 0 5 0 0 1 34
The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets 0 0 0 4 1 1 9 20
Therapeutic reference pricing and drug innovation incentives 0 0 0 0 1 2 5 17
Union collusion and intra-industry trade 0 0 0 27 0 0 1 155
When does remote electronic access (not) boost productivity? Longitudinal evidence from Portugal 0 0 0 10 1 1 2 29
Total Journal Articles 2 5 48 2,465 34 104 330 10,846
1 registered items for which data could not be found


Book File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Public Health Care 0 0 0 0 0 1 1 1
Public Health Care 0 0 0 0 0 0 0 0
Total Books 0 0 0 0 0 1 1 1


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Patient Choice, Mobility and Competition Among Health Care Providers 0 0 0 0 1 1 7 32
Total Chapters 0 0 0 0 1 1 7 32


Statistics updated 2025-09-05